APA

Richardson P. G., Blood E., Mitsiades C. S., Jagannath S., Zeldenrust S. R., Alsina M., Schlossman R. L., Rajkumar S. V., Desikan K. R., Hideshima T., Munshi N. C., Kelly-Colson K., Doss D., McKenney M. L., Gorelik S., Warren D., Freeman A., Rich R., Wu A., Olesnyckyj M., Wride K., Dalton W. S., Zeldis J., Knight R., Weller E. & Anderson K. C. (20070109). A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma. : Blood.

Chicago

Richardson Paul G, Blood Emily, Mitsiades Constantine S, Jagannath Sundar, Zeldenrust Steven R, Alsina Melissa, Schlossman Robert L, Rajkumar S Vincent, Desikan K Raman, Hideshima Teru, Munshi Nikhil C, Kelly-Colson Kathleen, Doss Deborah, McKenney Mary L, Gorelik Svetlana, Warren Diane, Freeman Andrea, Rich Rebecca, Wu Anfang, Olesnyckyj Marta, Wride Kenton, Dalton William S, Zeldis Jerome, Knight Robert, Weller Edie and Anderson Kenneth C. 20070109. A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma. : Blood.

Harvard

Richardson P. G., Blood E., Mitsiades C. S., Jagannath S., Zeldenrust S. R., Alsina M., Schlossman R. L., Rajkumar S. V., Desikan K. R., Hideshima T., Munshi N. C., Kelly-Colson K., Doss D., McKenney M. L., Gorelik S., Warren D., Freeman A., Rich R., Wu A., Olesnyckyj M., Wride K., Dalton W. S., Zeldis J., Knight R., Weller E. and Anderson K. C. (20070109). A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma. : Blood.

MLA

Richardson Paul G, Blood Emily, Mitsiades Constantine S, Jagannath Sundar, Zeldenrust Steven R, Alsina Melissa, Schlossman Robert L, Rajkumar S Vincent, Desikan K Raman, Hideshima Teru, Munshi Nikhil C, Kelly-Colson Kathleen, Doss Deborah, McKenney Mary L, Gorelik Svetlana, Warren Diane, Freeman Andrea, Rich Rebecca, Wu Anfang, Olesnyckyj Marta, Wride Kenton, Dalton William S, Zeldis Jerome, Knight Robert, Weller Edie and Anderson Kenneth C. A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma. : Blood. 20070109.